Clinical trial
STAR - Study of TTP and Rituximab, A Randomized Clinical Trial
NCT00799773 is registered in ClinicalTrials.gov with Carelon Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- STAR - Study of TTP and Rituximab, A Randomized Clinical Trial
- Lead sponsor
- Carelon Research
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- April 30, 2009
- Completion date
- February 28, 2010
- Enrollment
- 3 (actual)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.
thrombotic thrombocytopenic purpura